REGENXBIO Inc(NASDAQ:RGNX) 
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates ...
Website: http://www.regenxbio.com
Founded: 2008
Full Time Employees: 257
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 6.45
H 6.54
L 6.26
C 6.29
V 1,087,615
10EMA 6.29
20EMA 6.29
60EMA 6.29
120EMA 6.29
250EMA 6.29